We Help Companies Find New Sales Opportunities
Avacta Group of Wetherby has sold its Optim protein analysis division to US-based Unchained Labs for up to £3.3m.
Avacta Group is to acquire Aptuscan for £1.5m, in order to expand its proprietary reagents and consumables business, and the deal will be funded by a £5.1m share placing.
Avacta is to relocate its pharmaceutical testing laboratory and 25 jobs from York to its Thorp Arch site in Wetherby in August.
Avacta has acquired Reactivlab, the Glasgow-based veterinary diagnostics firm, for up to £5m.
Avacta Group is to raise £2m in a share placing to fund the expansion of its York-based pharmaceuticals and diagnostic tests business.
Avacta Group has acquired YorkTest Veterinary Services, the York-based veterinary laboratory services firm, for up to £0.8m.
Avacta Group has acquired Theragenetics, the medical diagnostics company with offices in London and the US, for up to £2m.
Avacta Group is to acquire Curidium Medica, the London-based biotechnology and diagnostics firm, for about £6.2m.
Avacta Group is to acquire Oxford Medical Diagnostics, the gas-detection technology company, for an initial £3m.
Avacta is to raise £1m in a flotation on Aim to fund the expansion of its York-based laser detection technology business.